🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: • To evaluate the safety and tolerability of cAd3-EBO-S...
Status
Completed
Location
Oklahoma Blood Institute (OBI)
Start Date
2021-01-06
Trial ID
NCT04723602
Treatments Being Tested
This is a non-interventional, multicenter, observational, international stu...
Status
Recruiting
Location
Arthur M. Blank Hospital
Start Date
2020-03-17
Trial ID
NCT04023019
The purpose of this study is to evaluate whether rThrombin is safe when use...
Status
Completed
Location
Richard M. Fairbanks Burn Center, Wishard Hospital
Start Date
2006-08
Trial ID
NCT00371215
Treatments Being Tested
The purpose of this study is to determine whether recombinant human Thrombi...
Status
Completed
Location
Cardio Thoracic Surgeons, P.C.
Start Date
2005-10
Trial ID
NCT00245336
Treatments Being Tested
A multicenter, stratified randomized, double-blind, placebo-controlled, pha...
Status
Completed
Location
The First Affiliated Hospital, Zhejiang University School of Medicine
Start Date
2019-11-11
Trial ID
NCT04459871
Treatments Being Tested
The objective of this study is to assess the safety and immunogenicity of r...
Status
Completed
Location
Arizona Burn Center
Start Date
2009-03
Trial ID
NCT00859547
Treatments Being Tested
This study is a prospective randomized trial examining the effect of topica...
Status
Terminated
Location
NYU Langone Health
Start Date
2021-03-24
Trial ID
NCT04814433
The objective of this study is to assess the immunogenicity and safety of r...
Status
Completed
Location
Tuscon Orthopaedic Institute
Start Date
2009-01
Trial ID
NCT00813904
Treatments Being Tested
This study is conducted globally. The aim of this study is to describe the ...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2005-10
Trial ID
NCT01779921
rhThrombin is a serine protease from human.The study is to assess the Safet...
Status
Completed
Location
Zhiwei Li
Start Date
2017-11-29
Trial ID
NCT03611426
Treatments Being Tested